Biodel Inc. Reports First Quarter Fiscal Year 2009 Financial Results and Clinical Update

February 6, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

DANBURY, Conn.--(BUSINESS WIRE)--Biodel Inc. (Nasdaq: BIOD) today reported financial results for the first quarter ended December 31, 2008 and provided an update on recent clinical findings with its lead product candidate, VIAject™.

Twitter
LinkedIn
Facebook
Email
Print

Earnings